Biohaven Says In RESILIENT SMA Study, Taldefgrobep Alfa Showed Clinically Meaningful Improvements In Motor Function At All Timepoints On The Motor Function Measurement-32 Scale, But The Treatment Arm Did Not Statistically Separate On The Primary...
Biohaven Says In RESILIENT SMA Study, Taldefgrobep Alfa Showed Clinically Meaningful Improvements In Motor Function At All Timepoints On The Motor Function Measurement-32 Scale, But The Treatment Arm Did Not Statistically Separate On The Primary...
biohaven在RESILIENt SMA研究中表示，Taldefgrobep alfa在运动功能测量-32量表的所有时间点上显示出临床意义的运动功能改善，但治疗组在主要指标上没有统计学上的分离...
Biohaven Says In RESILIENT SMA Study, Taldefgrobep Alfa Showed Clinically Meaningful Improvements In Motor Function At All Timepoints On The Motor Function Measurement-32 Scale, But The Treatment Arm Did Not Statistically Separate On The Primary Outcome At Week 48 Compared To The Placebo+Standard Of Care Group
biohaven表示，在RESILIENt SMA研究中，Taldefgrobep alfa在运动功能测量-32量表的所有时间点上显示出在运动功能方面的临床显著改善，但治疗组在第48周的主要结果上未能在统计上与安慰剂+标准护理组分离。
热门讨论
中概股财报季火热：惊喜盈利能否延续涨势？
1. 哪些行业可能成为本轮中概股财报季的市场焦点？ 2. 在政府强调科技创新和可持续发展的背景下，你认为哪些行业具有最大的增长潜力？
Moomoo News Global
03/04 23:26
中国两会：会议前后股票价格走势的主要要点